Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma

Background Autologous BCMA-specific CAR T-cell therapies have substantial activity in multiple myeloma (MM). However, due to logistical limitations and BCMAlow relapses, there is a need for alternatives. UCARTCS1 cells are ‘off-the-shelf’ allogeneic CAR T-cells derived from healthy donors targeting...

Cijeli opis

Bibliografski detalji

Glavni autori:	Roman Galetto, Tuna Mutis, Sonja Zweegman, Isabelle Chion-Sotinel, Charlotte L B M Korst, Chloe O’Neill, Wassilis S C Bruins, Meliha Cosovic, Inoka Twickler, Christie P M Verkleij, Diane Le Clerre, Maria Themeli, Niels W C J van de Donk
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2024-07-01
Serija:	Journal for ImmunoTherapy of Cancer
Online pristup:	https://jitc.bmj.com/content/12/7/e008769.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!